Here's the live share price of Ambalal Sarabhai Enterprises along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Ambalal Sarabhai Enterprises has gained 13.31% CAGR. Over the past year, the corresponding return has been -39.97%.
Ambalal Sarabhai Enterprises’s current P/E of 19.56x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ambalal Sarabhai Enterprises | 0.15 | 0.83 | -1.42 | -9.90 | -39.97 | 3.08 | 13.31 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Ambalal Sarabhai Enterprises has declined 39.97% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Ambalal Sarabhai Enterprises has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 32.74 | 32.42 |
| 10 | 32.69 | 32.67 |
| 20 | 33.57 | 32.89 |
| 50 | 32.8 | 33.1 |
| 100 | 33.91 | 34.38 |
| 200 | 37.69 | 37.97 |
In the latest quarter, Ambalal Sarabhai Enterprises remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.34%, and public shareholding moved up to 68.32% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 27, 2025, 10:32 PM IST | Ambalal Sarabhai - Announcement Under Regulation 30 Of SEBI (LODR) |
| Oct 10, 2025, 4:19 PM IST | Ambalal Sarabhai - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 11:25 PM IST | Ambalal Sarabhai - Announcement Under Regulation 30 Of SEBI (LODR) |
| Aug 13, 2025, 10:07 PM IST | Ambalal Sarabhai - Results - Financial Results For The Quarter Ended 30.06.2025 |
| Aug 13, 2025, 9:57 PM IST | Ambalal Sarabhai - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.08.2025 |
Ambalal Sarabhai Enterprises Ltd. is a Public Limited Listed company incorporated on 05/06/1978 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L52100GJ1978PLC003159 and registration number is 003159. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 4.04 Cr. and Equity Capital is Rs. 76.63 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ambalal Sarabhai Enterprises is ₹32.69 as on Oct 31, 2025.
The Ambalal Sarabhai Enterprises is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Ambalal Sarabhai Enterprises is ₹250.51 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Ambalal Sarabhai Enterprises are ₹32.93 and ₹32.02.
The 52-week high/low is the highest and lowest price at which Ambalal Sarabhai Enterprises stock has traded in the past 52-week or nearly a year. The 52-week high of Ambalal Sarabhai Enterprises is ₹68.00 and 52-week low of Ambalal Sarabhai Enterprises is ₹30.00 as on Oct 31, 2025.
The Ambalal Sarabhai Enterprises has shown returns of 1.55% over the past day, 0.83% for the past month, -1.42% over 3 months, -39.97% over 1 year, 3.08% across 3 years, and 13.31% over 5 years.
P/E ratio of and PB ratio of Ambalal Sarabhai Enterprises are 19.56 and 1.79 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.